Filter Results
:
(4,732)
Show Results For
-
All HBS Web
(4,732)
- People (16)
- News (1,795)
- Research (2,166)
- Events (2)
- Multimedia (198)
- Faculty Publications (1,763)
Show Results For
-
All HBS Web
(4,732)
- People (16)
- News (1,795)
- Research (2,166)
- Events (2)
- Multimedia (198)
- Faculty Publications (1,763)
- November 2015 (Revised October 2016)
- Case
athenahealth's More Disruption Please Program
By: Robert F. Higgins and Erin Trimble
Keywords:
Health Care Entrepreneurship;
Health Care;
Healthcare;
Healthcare Industry;
Healthcare Innovation;
Healthcare IT;
Disruptive Innovation;
Disruptive Change;
Health Industry;
Boston
Higgins, Robert F., and Erin Trimble. "athenahealth's More Disruption Please Program." Harvard Business School Case 816-060, November 2015. (Revised October 2016.)
- 01 Jun 2009
- News
Doctor Innovation—Shaking up the Health System
- July 2016 (Revised July 2019)
- Teaching Plan
Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)
By: Nori Gerardo Lietz and Ricardo Andrade
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and...
View Details
- 28 Mar 2014
- News
Start-Up Aims to Reinvent Health Insurance
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
government's role in U.S. healthcare? What do you think? To Read More: Robert H. Frank, "A Health Care Plan So Simple, Even Stephen Colbert Couldn't Simplify It," The New York Times, February 18, 2007, p....
View Details
- April 2018
- Case
Revitalizing the Cherokee Nation Health System
By: Tom Nicholas and Ross Bloom
Nicholas, Tom, and Ross Bloom. "Revitalizing the Cherokee Nation Health System." Harvard Business School Case 818-123, April 2018.
- 18 Oct 2016
- Op-Ed
Why Business Should Invest in Community Health
Foundation shows how the unhealthiness of an industry’s workers correlates closely with the unhealthiness of the communities in which those workers and their families reside. Companies that invest in community health have the potential to...
View Details
- 30 Oct 2015
- News
Can Providers and Insurers Team Up to Fix Health Insurance?
- April 2000 (Revised July 2001)
- Case
Oxford Health Plans (B): Crisis Strikes
By: Robert S. Huckman and Jody H. Gittell
Supplements the (A) case. A rewritten version of an earlier supplement.
View Details
Huckman, Robert S., and Jody H. Gittell. "Oxford Health Plans (B): Crisis Strikes." Harvard Business School Case 800-366, April 2000. (Revised July 2001.)
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Africa;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- 16 May 2014
- News
Health cuts ‘wrong way’ to reform system, Harvard expert says
- 01 Dec 2007
- News
Where Are the Innovators in Health Care?
No sector of our economy is more in need of innovation than health care, yet its many regulations handcuff entrepreneurs. A consumer-driven health-care system will unlock these shackles to bring about a...
View Details
- 05 May 2016
- News
The Real Cost of Ignoring Mental Health in the Workplace
- August 1997
- Article
Preventable Adverse Drug Events in Hospitalized Patients: A Comparative Study of Intensive Care and General Care Units
By: D. J. Cullen, J. Sweitzer, D. W. Bates, E. Burdick, A. Edmondson and L. L. Leape
Cullen, D. J., J. Sweitzer, D. W. Bates, E. Burdick, A. Edmondson, and L. L. Leape. "Preventable Adverse Drug Events in Hospitalized Patients: A Comparative Study of Intensive Care and General Care Units." Critical Care Medicine 25, no. 8 (August 1997): 1289–1297.
- May 2008 (Revised April 2018)
- Case
The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care
By: Michael E. Porter and Sachin H. Jain
In 2006, University of Texas MD Anderson Cancer Center was an internationally leading institution for cancer care, education, and research. Since 1996, it had successfully reorganized itself from a cancer hospital that was physically organized around clinical...
View Details
Keywords:
Buildings and Facilities;
Health Disorders;
Organizational Structure;
Medical Specialties;
Organizational Change and Adaptation;
Value Creation;
Service Delivery;
Research;
Health Care and Treatment;
Health Industry;
Health Industry;
Texas
Porter, Michael E., and Sachin H. Jain. "The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care." Harvard Business School Case 708-487, May 2008. (Revised April 2018.)
- 07 Dec 2015
- Video
Mark Bertolini, CEO of Aetna, talks about inefficiency in care delivery
- 2016
- Blog
Building A Culture of Health - John A. Quelch: The Marketing of Prevention
By: John A. Quelch
The US will devote 17.5% of GDP to health care this year, around $3 trillion. Yet only 3 percent of that will be spent on prevention, including both primary prevention (preventing illness in the first place) and secondary prevention (preventing sick people getting...
View Details
Keywords:
Healthcare;
Healthcare Marketing;
Prevention;
Wellbeing;
Health;
Marketing;
Health Industry;
Health Industry;
Health Industry;
Europe;
North and Central America
Quelch, John A. "The Marketing of Prevention." Building A Culture of Health - John A. Quelch (blog). May 12, 2016. http://johnquelch.org/the-marketing-of-prevention/.
- May 2016
- Case
AbbVie
By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars...
View Details
- 01 Sep 2011
- News
Student Trio Advance Health Payment Reform
Related Links Read about other efforts in healthcare delivery Three HBS students spent much of the last academic year helping a leading Boston hospital answer one of the most important questions in health-care management: how to create a new payment system that saves...
View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
otherwise take a decade to diagnose. But NextGen Jane is building more diseases into the pipelines. “There are so many understudied areas in women’s health we could explore,” Tariyal says. Illustration by Marcos Chin The Question: “The...
View Details
Keywords:
Jen McFarland Flint